Dr. Matthew W. Johnson, Ph.D. joins Jillian this week. He’s the Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins and the world’s most widely published expert on psychedelics. His research in the clinical use of psychedelics has helped people transform their lives. From quitt

Summary: Between Black Friday and Cyber Monday there were over 61 million transactions, but not because inflation is getting better. I sit down and chat with Matthew Johnson, who points out that, as businesses make it increasingly easy to pay using credit, interest on these lines of credit is simultaneously skyrocketin

In all actuality is not a huge surprise that PPI increased.  When you consider the economy as a large heavy car, (think 1976 Lincoln Continental) this thing was completely stalled blocking the middle of the road in 2020.  That’s good for no one, so the motivation is “do something!”   The government starting pushing on

Summary: With the appearance of inflation getting better and prices going down, is it a safe time for investors? Furthermore, what should you be investing in right now? Matthew Johnson from Johnson Wealth and Income Management comes on the show to talk about this. Growing up with a Father that ran a business himself, M

Where would we be if psychedelic research was never halted? We’ll never be able to answer that question, but the exciting thing is that we are currently living through the renaissance of psychedelic science, and today’s podcast is with one of the leading experts of this movement. Dr. Matthew W. Johnson, Ph.D., is a Pro

This episode I discuss medical research on psychedelic compounds with Dr. Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine. We discuss the biology and medical clinical-trial uses of psilocybin, MDMA, ayahuasca, DMT, and LSD. Dr. Johnson teaches us what the clinical tr